These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6311014)

  • 1. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.
    King JW; Beam TR; Neu HC; Smith LG
    Am J Med; 1983 Aug; 75(2A):90-5. PubMed ID: 6311013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
    Sattler FR; Hall S; Hanna CE; Green EA
    Am J Med; 1983 Aug; 75(2A):106-12. PubMed ID: 6310997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections.
    Ward TT; Amon MB; Krause LK
    Am J Med; 1983 Aug; 75(2A):85-9. PubMed ID: 6311011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections).
    File TM; Tan JS
    Am J Med; 1983 Aug; 75(2A):100-5. PubMed ID: 6310996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections.
    Nelson JD; Kusmiesz H; Shelton S
    Am J Med; 1983 Aug; 75(2A):125-9. PubMed ID: 6311000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
    Zaremba M; Zukowska-Nytko K; Borowski J
    Med Dosw Mikrobiol; 1982; 34(3-4):149-58. PubMed ID: 6302412
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral amdinocillin for treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1983 Aug; 75(2A):82-4. PubMed ID: 6311010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I; Gibson G; Sawyer K; Samel C; Skalina D
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):87-96. PubMed ID: 3383549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
    Lawson RD; Estey EH; Bodey GP
    Am J Med; 1983 Aug; 75(2A):113-8. PubMed ID: 6310998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of clinical experience with amdinocillin monotherapy and comparative studies.
    Demos CH; Green E
    Am J Med; 1983 Aug; 75(2A):72-81. PubMed ID: 6311009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
    JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria.
    Eng RH; Liu R; Smith SM; Johnson ES; Cherubin CE
    Chemotherapy; 1988; 34(1):18-26. PubMed ID: 3258230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mecillinam in urinary tract infections and in septicaemia.
    Frimodt-Møller N; Ravn TJ
    Infection; 1979; 7(1):35-7. PubMed ID: 217836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Kernéis S; Valade S; Geri G; Compain F; Lavollay M; Rostane H; Carbonnelle E; Mainardi JL
    Infect Dis (Lond); 2015; 47(11):789-95. PubMed ID: 26136072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.